IL-2: the first effective immunotherapy for human cancer

Area of Science:

• Immunology
• Oncology
• Biotechnology

Background:

• Interleukin-2 (IL-2) is crucial for T cell expansion and function.
• Cancer immunotherapies leverage the immune system to combat cancer.

Purpose of the Study:

• To summarize the role of IL-2 in developing effective cancer immunotherapies.
• To highlight IL-2's application in T cell expansion for cancer treatment.

Main Methods:

• Administration of IL-2 to expand T cells.
• Development of adoptive cell transfer therapies using IL-2 expanded lymphocytes.
• Genetic modification of T cells with TCRs or CARs for enhanced targeting.

Main Results:

• IL-2 therapy achieves durable, complete regressions in metastatic melanoma and renal cancer.
• IL-2 facilitates the expansion of tumor-infiltrating lymphocytes with anti-cancer activity.
• Genetically engineered T cells expanded in IL-2 show efficacy in various cancer types.

Conclusions:

• IL-2 is a foundational element in successful cancer immunotherapy.
• IL-2-based strategies, including cell transfer, offer potent treatments for advanced cancers.
• Advances in T cell engineering combined with IL-2 expansion broaden therapeutic applications.